Listed by the USPTO as VANNI, GEORGE STEVEN
Tech Center 1600 • Art Units: 1631 1657 1672 1686
This examiner grants 67% of resolved cases
VANNI, GEORGE STEVEN has resolved 606 cases in technology center 1600 and art unit 1631. The allowance rate is 66.8%, and the median time to allowance is 1489 days. Interviews are associated with a 25.2% lift in the allowance rate. The substantial record supports using these figures as a meaningful description of prosecution activity in this docket.
Foundation Medicine Inc., Samsung Electronics Co., Ltd., and BOE Technology Group Co., Ltd. are the listed leading companies. Kilpatrick Townsend & Stockton LLP - West Coast, Maschoff Brennan, and WILSON SONSINI GOODRICH & ROSATI are the listed leading firms. Counsel can identify recurring applicant and representative activity while evaluating interviews as a potentially useful part of prosecution strategy.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18397304 | METHOD FOR PREDICTING CELL CULTURE RESULT, CULTURE RESULT PREDICTION PROGRAM, AND CULTURE RESULT PREDICTION APPARATUS | Non-Final OA | FUJIFILM Corporation |
| 17102587 | METHOD AND APPARATUS FOR PREDICTING ANALYTE CONCENTRATION | Non-Final OA | SAMSUNG ELECTRONICS CO., LTD. |
| 17916540 | RNA-PROTEIN INTERACTION PREDICTION METHOD AND DEVICE, STORAGE MEDIUM AND ELECTRONIC DEVICE | Final Rejection | BOE Technology Group Co., Ltd. |
| 17110879 | METHOD OF HYPOGLYCEMIA RISK DETERMINATION | Final Rejection | ABBOTT DIABETES CARE INC. |
| 18257925 | METHODS, SYSTEMS AND RELATED ASPECTS FOR REAL-TIME PREDICTION OF ADVERSE OUTCOMES USING MACHINE LEARNING AND HIGH-DIMENSIONAL CLINICAL DATA | Non-Final OA | THE JOHNS HOPKINS UNIVERSITY |
| 17208110 | MOLECULE EMBEDDING USING GRAPH NEURAL NETWORKS AND MULTI-TASK TRAINING | Non-Final OA | Microsoft Technology Licensing, LLC |
| 17496758 | METHOD AND DEVICE FOR HIGH THROUGHPUT CELL DEFORMABILITY MEASUREMENTS | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18263106 | METHOD FOR MODELLING PRODUCTION OF CARBONATED SEDIMENTS AND THE EVOLUTION OF A SEDIMENTARY BASIN | Non-Final OA | TotalEnergies OneTech |
| 17313880 | SIZE-BASED ANALYSIS OF CELL-FREE TUMOR DNA FOR CLASSIFYING LEVEL OF CANCER | Non-Final OA | The Chinese University of Hong Kong |
| 17759194 | A METHOD OF ESTABLISHING A WHOLE-TISSUE EPIGENETIC CLOCK FOR AVIAN SPECIES | Non-Final OA | Evonik Operations GmbH |
| 18560861 | METHOD AND SYSTEM FOR PREDICTING MICROBIAL CULTURE CONCENTRATION | Non-Final OA | LG CHEM, LTD. |
| 17546735 | CANCER RISK STRATIFICATION BASED ON HISTOPATHOLOGICAL TISSUE SLIDE ANALYSIS | Non-Final OA | Ventana Medical Systems, Inc. |
| 18274675 | METHODS AND SYSTEMS FOR CHARACTERIZING AND TREATING COMBINED HEPATOCELLULAR CHOLANGIOCARCINOMA | Non-Final OA | Foundation Medicine, Inc. |
| 17612966 | SYSTEMS AND METHODS FOR EVALUATING TUMOR FRACTION | Non-Final OA | Foundation Medicine, Inc. |
| 17427002 | COMPOSITIONS, METHODS, AND SYSTEMS TO DETECT HEMATOPOIETIC STEM CELL TRANSPLANTATION STATUS | Non-Final OA | Sequenom, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy66.8% of resolved applications examined by George Steven Vanni were allowed (606 resolved cases), compared with 28.4% across Art Unit 1631 over the last five years.
This examiner's interview lift is +25.2 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by George Steven Vanni took 1,489 days on average from filing to allowance.
George Steven Vanni examines applications in Art Unit 1631 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
